News
Cell therapy in regenerative medicine from an industrial focus
On initiative of the TBDO, Dr. Miguel Mulet will provide an overview of cell therapy in regenerative medicine from an industrial focus and how this field illustrates particularly well, the challenges and risks of the trip from science to product during PRBB-CRG Session of Friday April 29th 2016 from 12:00-13:00. In this overview, he will touch various aspects:
- Cell therapy as a pharmaceutical product.
- How Mechanism of Action has been a moving target in parallel with product development.
- The intellectual property challenge of protecting inventions involving cells.
- Adapting biologics regulation to cell therapy.
- The long path of clinical development.
- Moving from a laboratory craft to industrial manufacturing.
- Commercialization and Market Access.
Miguel Mulet is Director of Strategy and New Projects in TiGenix, which is a leading European cell therapy company. His primary role at TiGenix is focused on aligning the functions that drive the cell therapy pipeline in Crohn’s Disease and Acute Myocardial Infarct. In addition, and besides business development activities to broaden the current pipeline, he is in charge of advancing the market readiness of the current platforms through implementation of new technologies and process improvement initiatives.
"Mind the Gap" 2016 - New call for projects now open
The Botín Foundation, with the "Mind the Gap" technology transfer investment programme, promotes the launch of business initiatives based on the results of scientific and technological research.
Projects may be submitted from 1 April to 28 April 2016
Contact the TBDO for more information and to request the application package.
CaixaImpulse 2016 - New call for projects now open
Aimed at researchers in the fields of Healthcare and Life Sciences, interested in transferring research assets from the lab to society and the market.
Projects may be submitted from 1 April to 15 July 2016
EiR Ion Arocena appointed new Managing Director of ASEBIO
Ion Arocena, one of our collaborators in the Entrepreneurs in Residence Programme, has been appointed new managing director of ASEBIO, the Spanish Bioindustry Association.
We wish him success in his new role!
Nereida Rodriguez joins the Entrepreneur-In-Residence Program
Nereida will collaborate with the TBDO department to enhance her proprietary technology, developed in conjunction with Xavier Gallego and Xavier Bosch: a next generation video tracking system able to automatically detect complex animal behaviors under any environmental condition.
Xavier Bosch joins the Entrepreneur-In-Residence Program
Xavier will collaborate with the TBDO department to enhance his proprietary technology, developed in conjunction with Xavier Gallego and Nereida Rodriguez: a next generation video tracking system able to automatically detect complex animal behaviors under any environmental condition.
TRANSFIERE 2016
On 10-11 February 2016, CRG will participate in Transfiere, the 5th European Forum for Science, Technology and Innovation, that will take place in the Palacio de Ferias y Congresos of Málaga.
Transfiere is the biggest professional and multisector forum of Spanish Innovation, in which participants can:
- Establish B2B contacts
- Transfer scientific knowledge and lines of technological research
- Show their innovative products and services
- Get to know the technological needs of Public Administration
Jordi Riulas joins the Entrepreneur-In-Residence Program
Jordi will collaborate with the TBDO team at CRG, analysing emerging business opportunities in the biotech market.
Rory Johnson and members of the TBDO participated in the ‘Personalized Medicines & Biomarkers 2015’ conference in London
Rory Johnson, Ramon y Cajal fellow at the Computational Biology of RNA Processing laboratory, together with members of the TBDO team, participated in the “Personalized Medicines & Biomarkers 2015” conference, held in London UK on 2nd and 3rd December 2015. The participation to this event, organized within the frame of the Science to Business (S2B) Concept Challenge (2015 Edition) award, was a great opportunity to learn from, and network with, leaders from biotech and pharma in the field of biomarker discovery and development. We expect that this valuable experience will help Rory promoting his entrepreneurial project, focused on non-invasive RNA treatment-decision biomarkers for chronic lymphocytic leukemia.
The TBDO participated in the BioFIT event in Strasbourg
BioFIT is the leading partnering event in Europe for open innovation, technology transfer and collaborative research in the field of Life Sciences: another great opportunity for partnering, networking and promoting CRG technologies.